The Next-Generation Medical Infrastructure Act is a key law that promotes the utilization of medical information and advances research and development in healthcare.
In line with its purpose, MAPI, as a government-certified business operator, is committed to the proper handling and safe utilization of medical information.
This page explains the outline of the Act and MAPI's specific initiatives.
The Next-Generation Medical Infrastructure Act (formally, the Act on Anonymized Medical Data That Are Meant to Contribute to Research and Development in the Medical Field) took effect in 2018. It aims to improve public health and the quality of healthcare by allowing medical information, processed so that individuals cannot be identified, to be used for medical research and development.
The Act opened the way for the valuable medical information held by medical institutions to be used more safely and smoothly for advanced R&D and the creation of new industries—drug development, improved treatments, and AI-based diagnostic support systems.
The Act promotes the advancement of medicine and healthcare and a society of healthy longevity through the utilization of medical information.
Its use is limited to purposes that serve the public interest, with strict guarantees of privacy protection and protection from disadvantage for individuals.
Government-certified operators (certified producers of anonymized or pseudonymized medical information) anonymize or pseudonymize the data so individuals cannot be identified, and manage and provide it under strict national standards.
Within this framework, MAPI, as a certified business operator, promotes the proper management and utilization of medical information and contributes to accelerating medical innovation.
Under the Next-Generation Medical Infrastructure Act, MAPI properly processes the medical information entrusted to it by medical institutions into anonymized or pseudonymized information, and provides it to organizations that wish to use it for research and development.
Anonymized information: information processed so that specific individuals cannot be identified and the original personal data cannot be restored to re-identify them. Processing methods and standards are strictly defined by law. Pseudonymized information: information processed so that specific individuals cannot be identified unless matched against other information. It retains more analytical value than anonymized information and can be used more flexibly under certain conditions.
MAPI creates and manages this information safely in accordance with national certification standards and provides it in forms appropriate to each research purpose, supporting innovation in healthcare. We enforce thorough security measures and rigorously screen the purposes of use and governance of recipient organizations.
For questions or consultations about the utilization of medical information under the Next-Generation Medical Infrastructure Act, or about the anonymized and pseudonymized information MAPI provides, please contact us below.
Representatives of medical institutions wishing to provide medical information
Researchers and companies considering the use of data for research purposes
Other general questions about MAPI's initiatives or the Act
Our specialists will be happy to assist you.
